Please login to the form below

Not currently logged in
Email:
Password:

CRF Health boosts leadership team

John Blakely and Risto Enbuska join the electronic patient reported outcomes firm
CRF Health John Blakely

CRF Health, a provider of electronic clinical outcomes assessment (eCOA) solutions for the life sciences industry, has two new additions to the company's executive leadership team.

John Blakeley, who joins as chief business officer, has 25 years of commercial experience in the clinical research and pharma sectors.

He was most recently chief commercial officer at Greenphire, a clinical payment technology firm, and prior to that worked in the same role at eResearch Technology (ERT).

Risto Enbuska has been named as chief technology officer, bringing his experience in R&D management and organisational leadership in a global environment to the role. In the new position, he will lead CRF Health's overall technology strategy and ensure continued innovation of the company's eCOA solutions for clinical trials.

Enbuska has over 20 years' experience in the telecom industry, progressing to various management positions at Nokia and directing their global R&D, quality and software development teams. Most recently, he has managed R&D operations across four countries at Comptel.

Rachael Wyllie, CEO at CRF Health, said: "The company has grown at a significant rate during the last 3 years and these additions to our executive leadership team are fundamental to help take us even further.

“The enhancements to our team will ensure we continue to create the right environment, processes, and procedures which will help us to continue supporting the ever increasing needs of our clients."

23rd December 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics